UltraGreen ai (ULG) Q3 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 TU earnings summary
29 Oct, 2026Executive summary
9M2026 continuing-operations revenue rose 35% YoY to US$131.8m, with growth in the US and ROW; cash and short-term investments were US$214m at 30 Sep 2026, with no debt.
New US competition is expected to weigh on 4Q2026 results and FY2027 US revenue and profitability; FY2026 revenue is expected below prior guidance of US$175–185m.
Financial highlights
9M2026 continuing revenue was US$131.8m versus US$97.6m in 9M2025; including discontinued operations, reported revenue increased 29% YoY. The 9M2025 comparison included US$4.4m from discontinued UltraLinQ operations.
3Q2026 revenue was US$45.2m; US revenue increased 47% YoY and ROW revenue increased 32% YoY.
Cash and short-term investments totaled US$214m at 30 Sep 2026, with no debt.
Outlook and guidance
FY2026 revenue is expected below prior guidance of US$175–185m, with new US market entrants weighing on 4Q2026 performance.
The full-year impact of competition is expected to extend into FY2027, pressuring US revenue and profitability; continued growth is expected outside the US.
Priorities include defending US market share, growing ROW, accelerating NIR camera rollouts and advancing new products and integrated solutions.
Latest events from UltraGreen ai
- ICG’s sub-10% penetration and expansion beyond hospitals underpin a broad growth runway.ULG
Investor presentation - Revenue up 24% and net profit up 53%, with strong margin and positive FY2026 outlook.ULG
H1 2026 - 24% revenue growth, strong margins, and robust FY2026 outlook with expanded global reach.ULG
H2 2025 - Q1 FY2026 volume up 7.8%, guidance reaffirmed, and global expansion accelerates growth.ULG
Q1 2026 TU